• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND DIAGNOSTICS DIVISION LONGFORD ALINITY I TOTAL B-HCG

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND DIAGNOSTICS DIVISION LONGFORD ALINITY I TOTAL B-HCG Back to Search Results
Catalog Number 07P51-20
Device Problem False Positive Result (1227)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 01/04/2020
Event Type  malfunction  
Manufacturer Narrative
Complete information for patient identifier = sid= (b)(6).There was no further patient information provided by the customer.An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.This report is being filed on an international product, list number 7p51-20 that has a similar product distributed in the us, list number 7p51-21.
 
Event Description
The customer reported a false positive alinity i b-hcg results on one (b)(6) year old female patient.On (b)(6) 2020 the patient arrived at the emergency room with abdominal pain.The initial b-hcg results were: (b)(6) 2020 sid (b)(6) = 36.16iu/l (>/=25.00 iu/l = positive).The hospital did not have a gynecologist on site at that time and the patient was not able to be treated for the pain due to the positive b-hcg result.On (b)(6) 2020 the patient had an echograph of the abdomen showing an inflamed appendix.The patient underwent immediate surgery.A new sample was drawn on (b)(6) 2020 = negative / a retest of the (b)(6) 2020 serum sample = <2.30iu/ l (
 
Manufacturer Narrative
A review of tickets determined normal complaint activity for lot 04527ui00, and no trends were identified for the product.Return testing was not completed as returns were not available.Historical performance of reagent lot 04527ui00 was evaluated using world wide data from abbottlink.The data determined that the patient median result for the lot is comparable to other lots in the field and confirms no systemic issue.A review of the manufacturing documentation did not identify any issues associated with the customer's observation.A review of the product labeling concluded that the issue is sufficiently addressed.Based on the investigation no product deficiency was identified for the alinity i total b-hcg reagent, lot 04527ui00.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALINITY I TOTAL B-HCG
Type of Device
B-HCG
Manufacturer (Section D)
ABBOTT IRELAND DIAGNOSTICS DIVISION LONGFORD
lisnamuck
co. longford
longford NA
EI  NA
MDR Report Key9632848
MDR Text Key221030531
Report Number3005094123-2020-00024
Device Sequence Number1
Product Code DHA
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 02/26/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/27/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/05/2020
Device Catalogue Number07P51-20
Device Lot Number04527UI00
Was Device Available for Evaluation? No
Date Manufacturer Received02/26/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ALINITY I PROCESSING MODULE, LN 03R65-01,; ALINITY I PROCESSING MODULE, LN 03R65-01,; SERIAL # (B)(6); SERIAL # (B)(6)
Patient Age19 YR
-
-